if CPACS is the ‘holy grail’ as per Aaron then why would a clinical cardio-oncologist turn down CAB role. Either it’s too soon have to wait until IND and US trial or contracts / conflicts of interest preventing engagement.
Perhaps we see more direction on this as part of Board changes version 2.0.
If I had to take a guess Susan won’t be CAB until validation in the clinic. It’s a huge reputational risk until then IMO. But also once in a lifetime and the pinnacle of what cardio-oncologists pursue their entire career.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.005(0.41%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.22 | $67.00K | 53.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2078 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 10000 | 1 |
View Market Depth
| Last trade - 15.11pm 25/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |